Targeted drugs for stomach cancer include cetuximab, panitumumab, nitolizumab, trastuzumab, afatinib and so on. According to the different targets against cells, targeted drugs for gastric cancer are categorized differently.
1. Drugs with anti-HER-2 monoclonal antibody: trastuzumab, patuximab, etc.
2. HER-2 tyrosine kinase inhibitors: such as lapatinib, afatinib, etc.
3. Anti-EGFR monoclonal antibodies: cetuximab, panitumumab, etc.
4. Anti-VEGT and VEGR monoclonal antibodies: such as Bevacizumab, Ranibizumab, etc.
When using gastric cancer targeted drugs, it is necessary to find out whether the corresponding target exists in the tumor cells, and it is necessary to pay attention to the fact that in the process of using the drugs, there may be adverse reactions such as heart and stomach pains, hair loss and so on. All drugs should be applied under the guidance of professional oncologists, and should not be used without authorization, which may have adverse consequences.